Interestingly, it is also reported that the expression levels of the pyroptosis effector gasdermin proteins may differ significantly across various cancer indications and intratumoral subtypes 63, where gasdermin-low cancer cell types tend to show enhanced resistance to RT and its pyroptosis-inducing effects 64, 65. Here, GSDMA is linked to cancer.